Injectables·200mg/ml·Best Seller

Deca Durabolin

Nandrolone Decanoate for significant muscle mass and joint recovery. A staple in bulking cycles with excellent nitrogen retention.

4.8· 267 reviews
Janoshik · Per-batch certificateCOA in commissioning
This SKU's certificate of analysis is in the Janoshik queue. Ships from current inventory; the lab report publishes here as soon as the lab signs it. View the public COA queue →

Compound

200mg/ml
In stock

At a glance

At a glance

Concentration
200mg/ml
Purity
USP-equivalent ≥98%
Route
Intramuscular injection
Storage
Room temperature, protect from light.

Deca Durabolin is the trade name for Nandrolone Decanoate, a 19-nortestosterone derivative in which the carbon-19 methyl group has been removed from the testosterone backbone. This seemingly minor structural change profoundly alters the compound's metabolism: nandrolone aromatizes at approximately 20% the rate of testosterone and undergoes 5-alpha reduction to the weaker metabolite dihydronandrolone (rather than the potent DHT), conferring a markedly lower androgenic profile relative to its anabolic potency. Nandrolone carries an anabolic rating of 125 and an androgenic rating of 37 — among the most favorable ratios of any anabolic steroid.

Nandrolone's mechanism of action extends beyond standard androgen receptor signaling. It enhances collagen synthesis and increases bone mineral content through direct stimulation of osteoblast proliferation. It promotes nitrogen retention with exceptional efficiency — studies demonstrate positive nitrogen balance at doses as low as 100mg/week, indicating that nandrolone shifts the protein synthesis-degradation equilibrium more effectively per milligram than testosterone. Additionally, nandrolone increases synovial fluid production and promotes joint cartilage repair, a property that has made it the compound of choice for researchers managing connective tissue stress from heavy training loads.

Deca Durabolin is the quintessential mass-building compound. It produces significant increases in lean body mass, muscle cross-sectional area, and total body water (both intracellular and extracellular). The gains are substantial but carry more water retention than compounds like Equipoise or Primobolan — this is an expected consequence of nandrolone's progestogenic activity and its effects on aldosterone signaling. The joint-protective properties are not cosmetic: researchers consistently report reduced pain in load-bearing joints, improved recovery from tendon and ligament stress, and enhanced training tolerance during high-volume phases.

This compound is appropriate for intermediate to advanced researchers pursuing significant mass accrual over extended cycles (12-16 weeks minimum). The long decanoate ester produces a very gradual onset — meaningful changes typically emerge at weeks 4-6 — and the compound rewards patience over aggression. Beginners should establish their testosterone response before introducing a 19-nor compound. Researchers with a history of mood-related sensitivity should approach nandrolone cautiously, as its progestogenic and neurosteroid activity can affect mood and libido in susceptible individuals.

Nandrolone Decanoate has a terminal half-life of approximately 6-12 days, with most researchers administering it once weekly. It must always be run alongside a testosterone base — the "Deca without test" protocol reliably produces erectile dysfunction and mood disturbance due to nandrolone's displacement of DHT at neurosteroid receptors. Standard practice is to maintain the testosterone dose at or above the nandrolone dose. PCT after Deca requires an extended waiting period (3-4 weeks after the last injection) before commencing SERM therapy, and many researchers incorporate HCG in the bridge period to maintain testicular function. Prolactin management with cabergoline or P5P (pyridoxal-5-phosphate) should be available on hand.

Dose ranges published in the peptide-research literature vary considerably. Research protocols should be designed by a qualified researcher and use the lowest effective dose consistent with the hypothesis being tested. Half-life determines dosing frequency — shorter half-lives usually require daily dosing, while long-acting analogues tolerate weekly administration.

For compound-specific dose theory, see the half-life dosing math guide and the stacking theory reference.

Certificate of Analysis

Independent lab verification

Purity
USP-equivalent ≥98%

Research disclaimer

For research and laboratory use only. Not for human or veterinary consumption. Novo Pharma sells to qualified researchers of legal age and ships to Canadian addresses only. See disclaimer and terms.

Read the research

Reference articles from the lab covering this compound.

Related compounds.

View all Injectables